We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRST icon
2551
Primis Financial Corp
FRST
$382M
$408K ﹤0.01%
30,697
-1,919
-6% -$25.8K
HBT icon
2552
HBT Financial
HBT
$1.21B
$407K ﹤0.01%
15,248
-331
-2% -$9.01K
MCFT icon
2553
MasterCraft Boat Holdings
MCFT
$588M
$407K ﹤0.01%
19,851
-675
-3% -$14.6K
PUBM icon
2554
PubMatic
PUBM
$581M
$407K ﹤0.01%
49,753
-3,101
-6% -$23.8K
PTLO icon
2555
Portillo's
PTLO
$315M
$406K ﹤0.01%
76,824
+331
+0.4% +$1.8K
JBS
2556
JBS N.V.
JBS
$40.4B
$406K ﹤0.01%
22,585
-1,462
-6% -$22.8K
BCML icon
2557
BayCom
BCML
$346M
$404K ﹤0.01%
13,607
-167
-1% -$4.91K
MRVI icon
2558
Maravai LifeSciences
MRVI
$997M
$404K ﹤0.01%
142,635
-7,928
-5% -$26.9K
PSNL icon
2559
Personalis
PSNL
$1.26B
$402K ﹤0.01%
63,111
-1,070
-2% -$9.03K
NGVC icon
2560
Vitamin Cottage Natural Grocers
NGVC
$691M
$400K ﹤0.01%
15,475
-139
-0.9% -$3.59K
FMAO icon
2561
Farmers & Merchants Bancorp
FMAO
$426M
$399K ﹤0.01%
15,540
-99
-0.6% -$2.58K
CERS icon
2562
Cerus
CERS
$587M
$398K ﹤0.01%
218,872
-10,515
-5% -$22.9K
ZUMZ icon
2563
Zumiez
ZUMZ
$320M
$398K ﹤0.01%
17,946
-1,077
-6% -$26.2K
PRME icon
2564
Prime Medicine
PRME
$533M
$398K ﹤0.01%
114,269
+5,860
+5% +$22.3K
ENTA icon
2565
Enanta Pharmaceuticals
ENTA
$372M
$397K ﹤0.01%
31,403
+2,554
+9% +$34.2K
SVV icon
2566
Savers
SVV
$1.4B
$395K ﹤0.01%
53,108
+214
+0.4% +$2.04K
ASND icon
2567
Ascendis Pharma A/S
ASND
$16.7B
$395K ﹤0.01%
1,725
-14
-0.8% -$3.14K
RCKT icon
2568
Rocket Pharmaceuticals
RCKT
$348M
$394K ﹤0.01%
110,196
-3,224
-3% -$12.8K
STRT icon
2569
STRATTEC Security
STRT
$358M
$394K ﹤0.01%
5,033
+23
+0.5% +$1.89K
ICLR icon
2570
Icon
ICLR
$12.8B
$393K ﹤0.01%
3,554
-882
-20% -$120K
ITIC
2571
Investors Title Co
ITIC
$533M
$393K ﹤0.01%
1,809
-46
-2% -$11.1K
NTR icon
2572
Nutrien
NTR
$32.7B
$393K ﹤0.01%
5,210
BLND icon
2573
Blend Labs
BLND
$409M
$392K ﹤0.01%
230,747
-12,677
-5% -$27.1K
ADCT icon
2574
ADC Therapeutics
ADCT
$146M
$390K ﹤0.01%
104,051
+13,368
+15% +$52.7K
MAGN
2575
Magnera Corp
MAGN
$488M
$390K ﹤0.01%
41,030
-80
-0.2% -$1.02K

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.